A tumor progression model for hepatocellular carcinoma: bioinformatic analysis of genomic data.

BACKGROUND & AIMS It is widely recognized that genomic abnormalities underpin the development of human cancers. Aberrant patterns of chromosomal changes may represent useful information that can be used in classifying the complex traits of liver cancer cases for the genetic events involved in tumor carcinogenesis, tumor progression, and prognosis. METHODS Genome-wide chromosomal aberrations of 158 hepatitis B virus-associated hepatocellular carcinoma (HCC) were studied by comparative genomic hybridization (CGH). By application of a self-organizing tree algorithm, statistically significant CGH events were used to construct an evolutionary tree that could infer patient subgroups with different degrees of tumor progression. The key CGH events in the subgroups were identified. The clinical significance of the groupings and the key CGH events were examined. RESULTS Based on the patterns of significant chromosomal aberrations derived, 3 HCC subgroups organized in an evolutionary tree were identified. The groupings possessed information reflecting the degrees of tumor progression, including numbers of chromosomal aberrations, tumor stages, tumor sizes, and disease outcome. Gains of 1q21-23 and 8q22-24 were identified as genomic events associated with the early development of HCC. Gain of 3q22-24, however, was identified as 1 of the late genomic events found to be associated with tumor recurrence and poor overall patient survival. CONCLUSIONS A tumor progression model for HCC was constructed and revealed chromosomal imbalances that were significantly associated with clinical pathologic characteristics of the disease. This model explains a significant part of the variations in clinical outcome among HCC patients.

[1]  Iscn.  International System for Human Cytogenetic Nomenclature , 1978 .

[2]  A. Tsiatis,et al.  Statistical analysis of cytogenetic abnormalities in human cancer cells. , 1982, Cancer genetics and cytogenetics.

[3]  P. Tiollais,et al.  Hepatitis B virus. , 1991, Scientific American.

[4]  R. Beasley.  Hepatitis B virus. The major etiology of hepatocellular carcinoma , 1988, Cancer.

[5]  J Piper,et al.  Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors , 1994, Genes, chromosomes & cancer.

[6]  F. Mitelman.  ISCN 1995 : an international system for human cytogenetic nomenclature (1995) : recommendations of the International Standing Committee on Human Cytogenetic Nomenclature : Memphis, Tennessee, USA, October 9-13, 1994 , 1995 .

[7]  P. Bedossa,et al.  Chromosomal aberrations in hepatocellular carcinomas: Relationship with pathological features , 1997, Hepatology.

[8]  J. Dopazo,et al.  Phylogenetic Reconstruction Using an Unsupervised Growing Neural Network That Adopts the Topology of a Phylogenetic Tree , 1997, Journal of Molecular Evolution.

[9]  M. Buendia,et al.  The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice , 1997, Oncogene.

[10]  N. Wong,et al.  Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis. , 1999, The American journal of pathology.

[11]  K. Okita,et al.  Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: Their relationship to clinicopathological features , 1999, Hepatology.

[12]  H. El‐Serag,et al.  Rising incidence of hepatocellular carcinoma in the United States. , 1999, The New England journal of medicine.

[13]  A. Schäffer,et al.  Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data. , 2000, Cancer research.

[14]  H. van Dekken,et al.  Molecular cytogenetic evaluation of virus‐associated and non‐viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias , 2000 .

[15]  H. Otto,et al.  “Slow-down” of the intrahepatic bile duct development between the 2nd and the 3rd trimester of gestation , 2000 .

[16]  M. Rubin,et al.  Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis. , 2001, Neoplasia.

[17]  Alfonso Valencia,et al.  A hierarchical unsupervised growing neural network for clustering gene expression patterns , 2001, Bioinform..

[18]  Expression of Nov, CYR61 and CTGF genes in human hepatocellular carcinoma. , 2001, Hepatology research : the official journal of the Japan Society of Hepatology.

[19]  D. Gisselsson,et al.  Multivariate analyses of genomic imbalances in solid tumors reveal distinct and converging pathways of karyotypic evolution , 2001, Genes, chromosomes & cancer.

[20]  P. Pineau,et al.  Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation , 2001, Molecular pathology : MP.

[21]  Michael Baudis,et al.  Progenetix.net: an online repository for molecular cytogenetic aberration data , 2001, Bioinform..

[22]  Kenneth H Buetow,et al.  A phylogenetic analysis identifies heterogeneity among hepatocellular carcinomas. , 2002, Hepatology.

[23]  H. Moch,et al.  Chromosomal Alterations in Hepatocellular Nodules by Comparative Genomic Hybridization: High-Grade Dysplastic Nodules Represent Early Stages of Hepatocellular Carcinoma , 2002, Laboratory Investigation.

[24]  Tony Pawson,et al.  β-Catenin and TCF Mediate Cell Positioning in the Intestinal Epithelium by Controlling the Expression of EphB/EphrinB , 2002, Cell.

[25]  A I Saeed,et al.  TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.

[26]  Kathleen R. Cho,et al.  Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas. , 2003, Cancer research.

[27]  J. Shih,et al.  Tumor-associated antigen L6 and the invasion of human lung cancer cells. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  Vijay Kumar,et al.  Hepatocellular carcinoma in a hepatitis B ‘x’ transgenic mouse model: A sequential pathological evaluation , 2003, Journal of gastroenterology and hepatology.

[29]  S. Strasberg,et al.  A common staging system for hepatocellular carcinoma , 2004 .

[30]  Mattias Höglund,et al.  Dissecting karyotypic patterns in malignant melanomas: Temporal clustering of losses and gains in melanoma karyotypic evolution , 2004, International journal of cancer.

[31]  M. Bouchard,et al.  The Enigmatic X Gene of Hepatitis B Virus , 2004, Journal of Virology.

[32]  The strategic role of staging in the treatment of HCC , 2004 .

[33]  Kunihiro Nishimura,et al.  Distinct Chromosomal Bias of Gene Expression Signatures in the Progression of Hepatocellular Carcinoma , 2004, Cancer Research.

[34]  Prognostic prediction in HCC: Did anybody expect it to be easy? , 2004 .

[35]  B. Young,et al.  Understanding cancer at the chromosome level: 40 years of progress. , 2004, European journal of cancer.

[36]  P. Schirmacher,et al.  Factors of transforming growth factor β signalling are co-regulated in human hepatocellular carcinoma , 2004, Virchows Archiv.

[37]  Pan‐Chyr Yang,et al.  CD13 (aminopeptidase N) can associate with tumor‐associated antigen L6 and enhance the motility of human lung cancer cells , 2005, International journal of cancer.